IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 226 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,011 | +38.1% | 25,700 | -14.6% | 0.01% | +25.0% |
| Q1 2023 | $732 | +36.3% | 30,100 | +19.9% | 0.00% | +33.3% |
| Q4 2022 | $537 | -99.8% | 25,100 | +45.9% | 0.00% | +50.0% |
| Q3 2022 | $309,000 | +87.3% | 17,200 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $165,000 | -42.9% | 17,200 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $289,000 | +7.8% | 17,200 | +7.5% | 0.00% | +100.0% |
| Q4 2021 | $268,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 5,339,518 | $210,056,638 | 52.85% |
| Chicago Capital Management, LLC | 359,561 | $14,145,130 | 18.12% |
| TCG Crossover Management, LLC | 2,448,829 | $96,336,933 | 15.80% |
| Vazirani Asset Management LLC | 180,000 | $7,081,200 | 11.94% |
| SYQUANT CAPITAL SAS | 406,686 | $15,999 | 11.62% |
| KRYGER CAPITAL Ltd | 2,523,853 | $99,288,377 | 10.16% |
| MPM BioImpact LLC | 1,214,662 | $47,784,803 | 9.62% |
| FNY Investment Advisers, LLC | 180,106 | $7,085 | 8.98% |
| HARVEST MANAGEMENT LLC | 213,500 | $8,399,090 | 7.25% |
| PRECEPT MANAGEMENT LLC | 130,000 | $5,114,200 | 6.94% |